Approved 9/2019. Criteria for use - For intra-abdominal infection from ESBL-producing bacteria with known sensitivity to eravacycline. Not for psuedomonas sp.

• Micromedex Drug Information
• Micromedex Care Notes
• Drugs@FDA
• FDA Daily Med Package Inserts